IASLC
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informat...
Vizitează neapărat site-ul podcastului și susține-i creatorul: www.iaslc.org
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania 02.08.2025 47:08
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC
IASLC - Stigma 29.07.2025 57:13
IASLC - Stigma by IASLC
LCC in Japanese: ASCO 2025 Highlights 25.07.2025 34:11
LCC in Japanese: ASCO 2025 Highlights by IASLC
Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer 23.07.2025 22:40
On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the University of Washington and Senior Vice President of the Fred Hutchinson Cancer Center and Dr. Kristen Marrone, Associate Professor of Oncology and Director of the Medical Oncology and Hematology Fell...
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC 18.07.2025 45:33
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
FDA Approval: Sunvozertinib for EGFR Exon 20 15.07.2025 41:03
FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC 11.07.2025 46:33
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC by IASLC
IASLC_WCLC 2025 Preview 08.07.2025 45:13
IASLC_WCLC 2025 Preview by IASLC
Virtual Tumor Board: Resectable EGFR NSCLC 01.07.2025 39:29
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The case explores resectable EGFR NSCLC.
FDA Approval: Taletrectinib and ROS1 NSCLC 24.06.2025 29:20
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor, for NSCLC with a ROS1 gene fusion. Dr. Enriqueta Felip and Dr. Jorge Nieva join the conversation to help review the data and offer help place this new agent in the proper perspective.
IASLC - ASCO 2025 Highlights 06.06.2025 55:15
ASCO 2025 Highlights Guests: Charu Aggarwal, MD, MPH Leslye M. Heisler Professor of Medicine Section Chief, Thoracic and Head & Neck Cancer Associate Director, Penn Center for Cancer Care Innovation (PC3I) University of Pennsylvania Patrick Forde, MBBCh Associate Professor Johns Hopkins University
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC 27.05.2025 33:15
In this episode, we will discuss the FDA approval of telisotuzumab vedotin, an antibody drug conjugate, for NSCLC with high c-MET expression. To help review the data and offer perspective on this new agent, I am joined by two expert thoracic oncologists. I want to welcome Dr. Mor Moskovitz, Head of the Thoracic Medical Oncology Service at Davidoff Cancer Center at the Rabin Medical Center in Petah...
LCC in Korean: Lung Cancer Updates & Future Directions 23.05.2025 33:41
LCC in Korean: Lung Cancer Updates & Future Directions by IASLC
Global Advances and Persistent Disparities in Lung Cancer Treatment 20.05.2025 47:50
Global Advances and Persistent Disparities in Lung Cancer Treatment by IASLC
Dr. Bryant Lin Teaching My Cancer 06.05.2025 41:26
Dr. Bryant Lin Teaching My Cancer by IASLC
AACR 2025 Highlights 02.05.2025 52:03
AACR 2025 Highlights by IASLC
What You Should Know About RET-Positive NSCLC: Live from TexasLung25 29.04.2025 30:48
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about the key information about RET-positive NSCLC, from diagnostic challenges to treatment selection. Join us in this lively discussion.
Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25 22.04.2025 40:46
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Eric Singhi and Dr. Misty Shields about patient education and communication. Tune in to hear the top things to discuss during your first oncology visit, including conflict and miscommunication resolution.
ELCC 2025 Highlights: Insights and Review of the Data 05.04.2025 43:04
Guest: Dr. Corey Langer is the Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania
The Microbiome and Immunotherapy for Lung Cancer 16.03.2025 50:55
The Microbiome and Immunotherapy for Lung Cancer by IASLC
LCC in Italian: Virtual Tumor Board - Resectable NSCLC 16.03.2025 50:54
LCC in Italian: Virtual Tumor Board - Resectable NSCLC by IASLC
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC 16.03.2025 28:05
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC
Virtual Tumor Board: Targeting Residual Disease 16.03.2025 49:11
Virtual Tumor Board: Targeting Residual Disease by IASLC
LCC in Korean: 2024 Lung Cancer Updates 16.03.2025 33:41
LCC in Korean: 2024 Lung Cancer Updates by IASLC
Live from TTLC25: Lung Cancer and Brain Metastasis 15.03.2025 19:11
Live from TTLC25: Lung Cancer and Brain Metastasis by IASLC
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice